Differential gene expression of Wnt signaling pathway in benign, premalignant, and malignant human breast epithelial cells

被引:4
作者
Wang, Yu-Zhou [1 ,2 ]
Han, Yu-Song [3 ]
Ma, Yu-Shui [1 ]
Jiang, Jun-Jian [4 ]
Chen, Zi-Xian [1 ]
Wang, Yi-Chao [1 ]
Che, Wu [1 ]
Zhang, Feng [1 ]
Xia, Qing [1 ]
Wang, Xiao-Feng [1 ]
机构
[1] Fudan Univ, Dept Orthoped Surg, Zhongshan Hosp, Shanghai 200032, Peoples R China
[2] Guangdong Med Coll, Ctr Canc, Affiliated Hosp, Zhanjiang 524002, Peoples R China
[3] Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Shanghai 200032, Peoples R China
[4] Fudan Univ, Dept Hand Surg, Huashan Hosp, Shanghai 200040, Peoples R China
关键词
Wnt pathway; Breast cancer; Prognosis; c-Myc; Microarray; HISTOLOGIC TYPES; XENOGRAFT MODEL; STEM-CELLS; CANCER; MCF10AT; PROGRESSION; DISEASE; ACTIVATION; GROWTH; LINES;
D O I
10.1007/s13277-012-0494-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To gain insight into the role of gene expression alterations in breast cancer progression, we conducted a comprehensive gene expression analysis of a series of cell lines derived from MCF10A, which include benign MCF10A cells, premalignant AT, and malignant CA1a tumor cells. We analyzed gene expression variation using the Agilent Human Genome Oligo Microarray with the goal of identifying gene-specific expression change events. In addition to a previously noted overexpression in oncogene MDM2, HRAS, and PCNA, our studies identified overexpression of Wnt signaling pathway in malignant breast cell lines. The Kaplan-Meier plot showed that high c-Myc expression in breast cancer was associated with tumor progression and the patient's poor survival. This study showed that the Wnt pathway has further provided a basis for the development of potential biomarker for breast cancer prognosis.
引用
收藏
页码:2317 / 2327
页数:11
相关论文
共 18 条
  • [1] Prospective identification of tumorigenic breast cancer cells
    Al-Hajj, M
    Wicha, MS
    Benito-Hernandez, A
    Morrison, SJ
    Clarke, MF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 3983 - 3988
  • [2] A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
    Brekman, Angelika
    Singh, Kathryn E.
    Polotskaia, Alla
    Kundu, Nandini
    Bargonetti, Jill
    [J]. BREAST CANCER RESEARCH, 2011, 13 (01):
  • [3] Dawson PJ, 1996, AM J PATHOL, V148, P313
  • [4] An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
    Gyoerffy, Balazs
    Lanczky, Andras
    Eklund, Aron C.
    Denkert, Carsten
    Budczies, Jan
    Li, Qiyuan
    Szallasi, Zoltan
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (03) : 725 - 731
  • [5] The Wnt signalling pathway
    Huelsken, J
    Behrens, J
    [J]. JOURNAL OF CELL SCIENCE, 2002, 115 (21) : 3977 - 3978
  • [6] Iravani S, 1998, INT J ONCOL, V12, P369
  • [7] Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines
    Kadota, Mitsutaka
    Yang, Howard H.
    Gomez, Bianca
    Sato, Misako
    Clifford, Robert J.
    Meerzaman, Daoud
    Dunn, Barbara K.
    Wakefield, Lalage M.
    Lee, Maxwell P.
    [J]. PLOS ONE, 2010, 5 (02):
  • [8] Wnt-Related Molecules and Signaling Pathway Equilibrium in Hematopoiesis
    Malhotra, Sachin
    Kincade, Paul W.
    [J]. CELL STEM CELL, 2009, 4 (01) : 27 - 36
  • [9] Wnt signalling in stem cells and cancer
    Reya, T
    Clevers, H
    [J]. NATURE, 2005, 434 (7035) : 843 - 850
  • [10] Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease
    Sadlonova, Andrea
    Mukherjee, Shibani
    Bowe, Damon B.
    Gault, Sandra R.
    Dumas, Nicole A.
    Van Tine, Brian A.
    Frolova, Natalya
    Page, Grier P.
    Welch, Danny R.
    Novak, Lea
    Frost, Andra R.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (03) : 1064 - 1076